Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA in 2020, Part 5: More Highlights From a Difficult Year

From increased member engagement to advocacy wins, reasons to celebrate.

APTA in 2020, Part 4: Fighting the Medicare Payment Cut

While a pandemic raged, together we advocated for the profession.

APTA in 2020, Part 3: Our Values in Action — Diversity, Equity, and Inclusion

Our efforts are rooted in the simple concept that greater diversity in the profession is key to its sustainability and, in turn, to achieving our transformative vision.

Clinical Continuing Education for Individuals Other Than Physical Therapists and Physical Therapist Assistants

Sep 20, 2019/Policies & Bylaws

HOD P06‐19‐68‐32:  Describes how individuals other than PTs and PTAs may participate in continuing education.

The Squeeze on Physical Therapy

Jun 2, 2022/Handouts

This handout shows how the impact of payment reduction can reduce the supply of physical therapist services.

APTA Practice Advisory: Vaccine Administration

Mar 18, 2021/Resource

Access information on vaccine administration at the state level, including current stance on permitting PTs and PTAs to administer the vaccine.

Board of Directors and Volunteers Whistleblower Protection

Feb 3, 2021/Policies & Bylaws

Board policy: This policy is intended to encourage and enable members of the Board of Directors and volunteers to raise serious concerns internally so that APTA can address and correct inappropriate conduct and actions.

APTA Academy of Orthopaedic Physical Therapy and Academy of Geriatric Physical Therapy: Physical Therapy Management of Older Adults With Hip Fracture (CPG+)

Feb 1, 2021/CPG

Provides evidence-based recommendations for physical therapy diagnosis, prognosis, intervention, and assessment of outcome in adults with hip fracture.

World Health Organization Guidelines on the Management of Chronic Pain in Children

Dec 22, 2020/CPG

These guidelines focus on physical, psychological, and pharmacological interventions for the management of primary and secondary chronic pain in children 0 to 19 years of age.